BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20875914)

  • 1. New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis.
    van der Steen S; de Nieuwenhof HP; Massuger L; Bulten J; de Hullu JA
    Gynecol Oncol; 2010 Dec; 119(3):520-5. PubMed ID: 20875914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population.
    Li J; Cai Y; Ke G; Xiang L; Wang L; Yang W; Wu X; Yang H
    Gynecol Oncol; 2015 May; 137(2):274-9. PubMed ID: 25759305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
    Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
    Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging for vulvar cancer.
    Hacker NF; Barlow EL
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):802-11. PubMed ID: 25842047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suggested modification to FIGO stage III vulvar cancer.
    Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
    Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review.
    Panici PB; Tomao F; Domenici L; Giannini A; Giannarelli D; Palaia I; Di Donato V; Musella A; Angioli R; Muzii L
    Gynecol Oncol; 2015 Jun; 137(3):373-9. PubMed ID: 25887098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical versus surgical staging systems in vulvar cancer.
    Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
    Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
    Bokhman JV; Maximov SJ; Ebert AD
    Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of staging systems for squamous cell carcinoma of the vulva.
    Hopkins MP; Reid GC; Johnston CM; Morley GW
    Gynecol Oncol; 1992 Oct; 47(1):34-7. PubMed ID: 1427397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva.
    Lataifeh I; Nascimento MC; Nicklin JL; Perrin LC; Crandon AJ; Obermair A
    Gynecol Oncol; 2004 Dec; 95(3):701-5. PubMed ID: 15581985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
    Fonseca-Moutinho JA; Coelho MC; Silva DP
    J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.
    Micheletti L; Preti M; Cintolesi V; Corvetto E; Privitera S; Palmese E; Benedetto C
    J Gynecol Oncol; 2018 Sep; 29(5):e61. PubMed ID: 30022627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content.
    Ballouk F; Ambros RA; Malfetano JH; Ross JS
    Mod Pathol; 1993 May; 6(3):371-5. PubMed ID: 8346186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis.
    Zhou J; Shan G
    Curr Med Res Opin; 2016 Jun; 32(6):1121-30. PubMed ID: 26959073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative study of former and latest FIGO staging of vulva cancer.
    Sun X; Zhang Y; Sun J; Feng S; Yan M; Cheng H
    Minerva Chir; 2012 Apr; 67(2):187-95. PubMed ID: 22487921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases.
    Lim D; Wang WL; Lee CH; Dodge T; Gilks B; Oliva E
    Gynecol Oncol; 2013 Feb; 128(2):322-6. PubMed ID: 23153591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult lymph node metastases in early stage vulvar carcinoma patients.
    Knopp S; Holm R; Tropé C; Nesland JM
    Gynecol Oncol; 2005 Nov; 99(2):383-7. PubMed ID: 16051338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the Editor referring to the manuscript entitled: "New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis" recently reported by van der Steen S. et al., (Gynecol Oncol 2010;119:520-5. Epub 2010 Sep 28).
    Sznurkowski JJ
    Gynecol Oncol; 2011 May; 121(2):424-5; author reply 423-4. PubMed ID: 21215438
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical staging of invasive squamous cell carcinoma of the vulva. Analysis of treatment and survival.
    Origoni M; Dindelli M; Ferrari D; Frigerio L; Rossi M; Ferrari A
    Int Surg; 1996; 81(1):67-70. PubMed ID: 8803710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.